Biz Break: Gilead's new hepatitis C drug produces huge sales in debut quarter

Home › Biz Break: Gilead's new hepatitis C drug produces huge sales in debut quarter

Today: Gilead Sciences demolishes earnings expectations thanks to powerful sales of breakthrough hepatitis C drug Sovaldi.

26.06	Rockline Industries Wins WOW Innovation Award
26.06	IMS Technologies Expands Calcinate Production Site
26.06	Horizon expert 'gave evidence based on informal chats'
26.06	Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06	Beckers Commits to Widespread Science Based Targets
26.06	PPG to Announce Second-quarter 2024 Results July 18
26.06	Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06	Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
More »

je.st